[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilars-On-Biologics Industry Market Research Report

January 2019 | 112 pages | ID: GBF4EA224A9MEN
Maia Research

US$ 2,960.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Biosimilars-On-Biologics market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Biosimilars-On-Biologics industrial chain, this report mainly elaborate the definition, types, applications and major players of Biosimilars-On-Biologics market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Biosimilars-On-Biologics market.

The Biosimilars-On-Biologics market can be split based on product types, major applications, and important regions.

Major Players in Biosimilars-On-Biologics market are:
Teva Pharmaceutical Industries Ltd.
LG Life Sciences
Biocon
Novartis
Synthon Pharmaceuticals, Inc.
Merck Serono
Celltrion
Hospira
Biogen idec Inc.

Major Regions play vital role in Biosimilars-On-Biologics market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Biosimilars-On-Biologics products covered in this report are:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide

Most widely used downstream fields of Biosimilars-On-Biologics market covered in this report are:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies

There are 13 Chapters to thoroughly display the Biosimilars-On-Biologics market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Biosimilars-On-Biologics Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Biosimilars-On-Biologics Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Biosimilars-On-Biologics.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Biosimilars-On-Biologics.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Biosimilars-On-Biologics by Regions (2013-2018).

Chapter 6: Biosimilars-On-Biologics Production, Consumption, Export and Import by Regions (2013-2018).

Chapter 7: Biosimilars-On-Biologics Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Biosimilars-On-Biologics.

Chapter 9: Biosimilars-On-Biologics Market Analysis and Forecast by Type and Application (2018-2023).

Chapter 10: Market Analysis and Forecast by Regions (2018-2023).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.
Global Biosimilars-On-Biologics Industry Market Research Report

1 BIOSIMILARS-ON-BIOLOGICS INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Definition of Biosimilars-On-Biologics
1.3 Biosimilars-On-Biologics Market Scope and Market Size Estimation
  1.3.1 Market Concentration Ratio and Market Maturity Analysis
  1.3.2 Global Biosimilars-On-Biologics Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
  1.4.1 Types of Biosimilars-On-Biologics
  1.4.2 Applications of Biosimilars-On-Biologics
  1.4.3 Research Regions
    1.4.3.1 North America Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.2 Europe Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.3 China Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.4 Japan Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.5 Middle East & Africa Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.6 India Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
    1.4.3.7 South America Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
  1.5.1 Drivers
    1.5.1.1 Emerging Countries of Biosimilars-On-Biologics
    1.5.1.2 Growing Market of Biosimilars-On-Biologics
  1.5.2 Limitations
  1.5.3 Opportunities
1.6 Industry News and Policies by Regions
  1.6.1 Industry News
  1.6.2 Industry Policies

2 INDUSTRY CHAIN ANALYSIS

2.1 Upstream Raw Material Suppliers of Biosimilars-On-Biologics Analysis
2.2 Major Players of Biosimilars-On-Biologics
  2.2.1 Major Players Manufacturing Base and Market Share of Biosimilars-On-Biologics in 2017
  2.2.2 Major Players Product Types in 2017
2.3 Biosimilars-On-Biologics Manufacturing Cost Structure Analysis
  2.3.1 Production Process Analysis
  2.3.2 Manufacturing Cost Structure of Biosimilars-On-Biologics
  2.3.3 Raw Material Cost of Biosimilars-On-Biologics
  2.3.4 Labor Cost of Biosimilars-On-Biologics
2.4 Market Channel Analysis of Biosimilars-On-Biologics
2.5 Major Downstream Buyers of Biosimilars-On-Biologics Analysis

3 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET, BY TYPE

3.1 Global Biosimilars-On-Biologics Value ($) and Market Share by Type (2013-2018)
3.2 Global Biosimilars-On-Biologics Production and Market Share by Type (2013-2018)
3.3 Global Biosimilars-On-Biologics Value ($) and Growth Rate by Type (2013-2018)
3.4 Global Biosimilars-On-Biologics Price Analysis by Type (2013-2018)

4 BIOSIMILARS-ON-BIOLOGICS MARKET, BY APPLICATION

4.1 Global Biosimilars-On-Biologics Consumption and Market Share by Application (2013-2018)
4.2 Downstream Buyers by Application
4.3 Global Biosimilars-On-Biologics Consumption and Growth Rate by Application (2013-2018)

5 GLOBAL BIOSIMILARS-ON-BIOLOGICS PRODUCTION, VALUE ($) BY REGION (2013-2018)

5.1 Global Biosimilars-On-Biologics Value ($) and Market Share by Region (2013-2018)
5.2 Global Biosimilars-On-Biologics Production and Market Share by Region (2013-2018)
5.3 Global Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.4 North America Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.5 Europe Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.6 China Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.7 Japan Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.8 Middle East & Africa Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.9 India Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
5.10 South America Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)

6 GLOBAL BIOSIMILARS-ON-BIOLOGICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)

6.1 Global Biosimilars-On-Biologics Consumption by Regions (2013-2018)
6.2 North America Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.3 Europe Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.4 China Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.5 Japan Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.6 Middle East & Africa Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.7 India Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
6.8 South America Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)

7 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET STATUS AND SWOT ANALYSIS BY REGIONS

7.1 North America Biosimilars-On-Biologics Market Status and SWOT Analysis
7.2 Europe Biosimilars-On-Biologics Market Status and SWOT Analysis
7.3 China Biosimilars-On-Biologics Market Status and SWOT Analysis
7.4 Japan Biosimilars-On-Biologics Market Status and SWOT Analysis
7.5 Middle East & Africa Biosimilars-On-Biologics Market Status and SWOT Analysis
7.6 India Biosimilars-On-Biologics Market Status and SWOT Analysis
7.7 South America Biosimilars-On-Biologics Market Status and SWOT Analysis

8 COMPETITIVE LANDSCAPE

8.1 Competitive Profile
8.2 Teva Pharmaceutical Industries Ltd.
  8.2.1 Company Profiles
  8.2.2 Biosimilars-On-Biologics Product Introduction
  8.2.3 Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
  8.2.4 Teva Pharmaceutical Industries Ltd. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.3 LG Life Sciences
  8.3.1 Company Profiles
  8.3.2 Biosimilars-On-Biologics Product Introduction
  8.3.3 LG Life Sciences Production, Value ($), Price, Gross Margin 2013-2018E
  8.3.4 LG Life Sciences Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.4 Biocon
  8.4.1 Company Profiles
  8.4.2 Biosimilars-On-Biologics Product Introduction
  8.4.3 Biocon Production, Value ($), Price, Gross Margin 2013-2018E
  8.4.4 Biocon Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.5 Novartis
  8.5.1 Company Profiles
  8.5.2 Biosimilars-On-Biologics Product Introduction
  8.5.3 Novartis Production, Value ($), Price, Gross Margin 2013-2018E
  8.5.4 Novartis Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.6 Synthon Pharmaceuticals, Inc.
  8.6.1 Company Profiles
  8.6.2 Biosimilars-On-Biologics Product Introduction
  8.6.3 Synthon Pharmaceuticals, Inc. Production, Value ($), Price, Gross Margin 2013-2018E
  8.6.4 Synthon Pharmaceuticals, Inc. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.7 Merck Serono
  8.7.1 Company Profiles
  8.7.2 Biosimilars-On-Biologics Product Introduction
  8.7.3 Merck Serono Production, Value ($), Price, Gross Margin 2013-2018E
  8.7.4 Merck Serono Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.8 Celltrion
  8.8.1 Company Profiles
  8.8.2 Biosimilars-On-Biologics Product Introduction
  8.8.3 Celltrion Production, Value ($), Price, Gross Margin 2013-2018E
  8.8.4 Celltrion Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.9 Hospira
  8.9.1 Company Profiles
  8.9.2 Biosimilars-On-Biologics Product Introduction
  8.9.3 Hospira Production, Value ($), Price, Gross Margin 2013-2018E
  8.9.4 Hospira Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
8.10 Biogen idec Inc.
  8.10.1 Company Profiles
  8.10.2 Biosimilars-On-Biologics Product Introduction
  8.10.3 Biogen idec Inc. Production, Value ($), Price, Gross Margin 2013-2018E
  8.10.4 Biogen idec Inc. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017

9 GLOBAL BIOSIMILARS-ON-BIOLOGICS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION

9.1 Global Biosimilars-On-Biologics Market Value ($) & Volume Forecast, by Type (2018-2023)
  9.1.1 Human growth hormone Market Value ($) and Volume Forecast (2018-2023)
  9.1.2 Erythropoietin Market Value ($) and Volume Forecast (2018-2023)
  9.1.3 Monoclonal antibodies Market Value ($) and Volume Forecast (2018-2023)
  9.1.4 Insulin Market Value ($) and Volume Forecast (2018-2023)
  9.1.5 Interferon Market Value ($) and Volume Forecast (2018-2023)
  9.1.6 Granulocyte-Colony Stimulating Factor Market Value ($) and Volume Forecast (2018-2023)
  9.1.7 Peptide Market Value ($) and Volume Forecast (2018-2023)
9.2 Global Biosimilars-On-Biologics Market Value ($) & Volume Forecast, by Application (2018-2023)
  9.2.1 Blood disorders Market Value ($) and Volume Forecast (2018-2023)
  9.2.2 Oncology diseases Market Value ($) and Volume Forecast (2018-2023)
  9.2.3 Chronic and autoimmune diseases Market Value ($) and Volume Forecast (2018-2023)
  9.2.4 Growth hormone deficiencies Market Value ($) and Volume Forecast (2018-2023)

10 BIOSIMILARS-ON-BIOLOGICS MARKET ANALYSIS AND FORECAST BY REGION

10.1 North America Market Value ($) and Consumption Forecast (2018-2023)
10.2 Europe Market Value ($) and Consumption Forecast (2018-2023)
10.3 China Market Value ($) and Consumption Forecast (2018-2023)
10.4 Japan Market Value ($) and Consumption Forecast (2018-2023)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2018-2023)
10.6 India Market Value ($) and Consumption Forecast (2018-2023)
10.7 South America Market Value ($) and Consumption Forecast (2018-2023)

11 NEW PROJECT FEASIBILITY ANALYSIS

11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 RESEARCH FINDING AND CONCLUSION

13 APPENDIX

13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilars-On-Biologics
Table Product Specification of Biosimilars-On-Biologics
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilars-On-Biologics
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate from 2013-2023
Table Different Types of Biosimilars-On-Biologics
Figure Global Biosimilars-On-Biologics Value ($) Segment by Type from 2013-2018
Figure Human growth hormone Picture
Figure Erythropoietin Picture
Figure Monoclonal antibodies Picture
Figure Insulin Picture
Figure Interferon Picture
Figure Granulocyte-Colony Stimulating Factor Picture
Figure Peptide Picture
Table Different Applications of Biosimilars-On-Biologics
Figure Global Biosimilars-On-Biologics Value ($) Segment by Applications from 2013-2018
Figure Blood disorders Picture
Figure Oncology diseases Picture
Figure Chronic and autoimmune diseases Picture
Figure Growth hormone deficiencies Picture
Table Research Regions of Biosimilars-On-Biologics
Figure North America Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Figure Europe Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table China Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table Japan Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table Middle East & Africa Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table India Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table South America Biosimilars-On-Biologics Production Value ($) and Growth Rate (2013-2018)
Table Emerging Countries of Biosimilars-On-Biologics
Table Growing Market of Biosimilars-On-Biologics
Figure Industry Chain Analysis of Biosimilars-On-Biologics
Table Upstream Raw Material Suppliers of Biosimilars-On-Biologics with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Biosimilars-On-Biologics in 2017
Table Major Players Biosimilars-On-Biologics Product Types in 2017
Figure Production Process of Biosimilars-On-Biologics
Figure Manufacturing Cost Structure of Biosimilars-On-Biologics
Figure Channel Status of Biosimilars-On-Biologics
Table Major Distributors of Biosimilars-On-Biologics with Contact Information
Table Major Downstream Buyers of Biosimilars-On-Biologics with Contact Information
Table Global Biosimilars-On-Biologics Value ($) by Type (2013-2018)
Table Global Biosimilars-On-Biologics Value ($) Share by Type (2013-2018)
Figure Global Biosimilars-On-Biologics Value ($) Share by Type (2013-2018)
Table Global Biosimilars-On-Biologics Production by Type (2013-2018)
Table Global Biosimilars-On-Biologics Production Share by Type (2013-2018)
Figure Global Biosimilars-On-Biologics Production Share by Type (2013-2018)
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Human growth hormone
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Erythropoietin
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Monoclonal antibodies
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Insulin
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Interferon
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Granulocyte-Colony Stimulating Factor
Figure Global Biosimilars-On-Biologics Value ($) and Growth Rate of Peptide
Table Global Biosimilars-On-Biologics Price by Type (2013-2018)
Table Global Biosimilars-On-Biologics Consumption by Application (2013-2018)
Table Global Biosimilars-On-Biologics Consumption Market Share by Application (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption Market Share by Application (2013-2018)
Table Downstream Buyers Introduction by Application
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Blood disorders (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Oncology diseases (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Chronic and autoimmune diseases (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Growth hormone deficiencies (2013-2018)
Table Global Biosimilars-On-Biologics Value ($) by Region (2013-2018)
Table Global Biosimilars-On-Biologics Value ($) Market Share by Region (2013-2018)
Figure Global Biosimilars-On-Biologics Value ($) Market Share by Region (2013-2018)
Table Global Biosimilars-On-Biologics Production by Region (2013-2018)
Table Global Biosimilars-On-Biologics Production Market Share by Region (2013-2018)
Figure Global Biosimilars-On-Biologics Production Market Share by Region (2013-2018)
Table Global Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table North America Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table Europe Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table China Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table Japan Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table Middle East & Africa Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table India Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table South America Biosimilars-On-Biologics Production, Value ($), Price and Gross Margin (2013-2018)
Table Global Biosimilars-On-Biologics Consumption by Regions (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption Share by Regions (2013-2018)
Table North America Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table Europe Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table China Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table Japan Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table Middle East & Africa Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table India Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Table South America Biosimilars-On-Biologics Production, Consumption, Export, Import (2013-2018)
Figure North America Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure North America Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure North America Biosimilars-On-Biologics SWOT Analysis
Figure Europe Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure Europe Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure Europe Biosimilars-On-Biologics SWOT Analysis
Figure China Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure China Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure China Biosimilars-On-Biologics SWOT Analysis
Figure Japan Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure Japan Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure Japan Biosimilars-On-Biologics SWOT Analysis
Figure Middle East & Africa Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure Middle East & Africa Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure Middle East & Africa Biosimilars-On-Biologics SWOT Analysis
Figure India Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure India Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure India Biosimilars-On-Biologics SWOT Analysis
Figure South America Biosimilars-On-Biologics Production and Growth Rate Analysis
Figure South America Biosimilars-On-Biologics Consumption and Growth Rate Analysis
Figure South America Biosimilars-On-Biologics SWOT Analysis
Figure Top 3 Market Share of Biosimilars-On-Biologics Companies
Figure Top 6 Market Share of Biosimilars-On-Biologics Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table LG Life Sciences Production, Value ($), Price, Gross Margin 2013-2018E
Figure LG Life Sciences Production and Growth Rate
Figure LG Life Sciences Value ($) Market Share 2013-2018E
Figure LG Life Sciences Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Biocon Production, Value ($), Price, Gross Margin 2013-2018E
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2013-2018E
Figure Biocon Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Novartis Production, Value ($), Price, Gross Margin 2013-2018E
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2013-2018E
Figure Novartis Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Synthon Pharmaceuticals, Inc. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Synthon Pharmaceuticals, Inc. Production and Growth Rate
Figure Synthon Pharmaceuticals, Inc. Value ($) Market Share 2013-2018E
Figure Synthon Pharmaceuticals, Inc. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Merck Serono Production, Value ($), Price, Gross Margin 2013-2018E
Figure Merck Serono Production and Growth Rate
Figure Merck Serono Value ($) Market Share 2013-2018E
Figure Merck Serono Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Celltrion Production, Value ($), Price, Gross Margin 2013-2018E
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2013-2018E
Figure Celltrion Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Hospira Production, Value ($), Price, Gross Margin 2013-2018E
Figure Hospira Production and Growth Rate
Figure Hospira Value ($) Market Share 2013-2018E
Figure Hospira Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Biogen idec Inc. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Biogen idec Inc. Production and Growth Rate
Figure Biogen idec Inc. Value ($) Market Share 2013-2018E
Figure Biogen idec Inc. Market Share of Biosimilars-On-Biologics Segmented by Region in 2017
Table Global Biosimilars-On-Biologics Market Value ($) Forecast, by Type
Table Global Biosimilars-On-Biologics Market Volume Forecast, by Type
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Human growth hormone (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Human growth hormone (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Erythropoietin (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Erythropoietin (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Monoclonal antibodies (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Monoclonal antibodies (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Insulin (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Insulin (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Interferon (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Interferon (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2018-2023)
Figure Global Biosimilars-On-Biologics Market Value ($) and Growth Rate Forecast of Peptide (2018-2023)
Figure Global Biosimilars-On-Biologics Market Volume and Growth Rate Forecast of Peptide (2018-2023)
Table Global Market Value ($) Forecast by Application (2018-2023)
Table Global Market Volume Forecast by Application (2018-2023)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Blood disorders (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Oncology diseases (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Chronic and autoimmune diseases (2013-2018)
Figure Global Biosimilars-On-Biologics Consumption and Growth Rate of Growth hormone deficiencies (2013-2018)
Figure Market Value ($) and Growth Rate Forecast of Growth hormone deficiencies (2018-2023)
Figure Market Volume and Growth Rate Forecast of Growth hormone deficiencies (2018-2023)
Figure North America Market Value ($) and Growth Rate Forecast (2018-2023)
Table North America Consumption and Growth Rate Forecast (2018-2023)
Figure Europe Market Value ($) and Growth Rate Forecast (2018-2023)
Table Europe Consumption and Growth Rate Forecast (2018-2023)
Figure China Market Value ($) and Growth Rate Forecast (2018-2023)
Table China Consumption and Growth Rate Forecast (2018-2023)
Figure Japan Market Value ($) and Growth Rate Forecast (2018-2023)
Table Japan Consumption and Growth Rate Forecast (2018-2023)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2018-2023)
Table Middle East & Africa Consumption and Growth Rate Forecast (2018-2023)
Figure India Market Value ($) and Growth Rate Forecast (2018-2023)
Table India Consumption and Growth Rate Forecast (2018-2023)
Figure South America Market Value ($) and Growth Rate Forecast (2018-2023)
Table South America Consumption and Growth Rate Forecast (2018-2023)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery%%


More Publications